Results for tag: "Optical Biopsy"

Optical biopsy is a diagnostic technique in the field of In Vitro Diagnostics (IVD) that involves the use of light to non-invasively examine tissues in the body for disease, including cancer. This technology typically uses imaging and spectroscopy methods, such as confocal laser endomicroscopy, optical coherence tomography (OCT), and fluorescence imaging, to provide real-time and high-resolution images of tissue morphology and biochemistry. The key advantage of optical biopsy over traditional biopsy is that it allows for the immediate assessment of tissues without the need for excision and histopathological analysis, potentially reducing the time for diagnosis and treatment planning. In the context of IVD, optical biopsy serves as an adjunctive or alternative tool for histological and cytological analysis, expanding the capabilities of laboratory medicine into the realms of living tissue examination. It can be particularly useful in settings such as gastroenterology for the assessment of gastrointestinal lesions or during endoscopic procedures where quick visualization and assessment of tissue can guide clinical decisions. Notable companies in the optical biopsy market include Mauna Kea Technologies, which offers the Cellvizio system—a confocal laser endomicroscopy platform, NinePoint Medical with its NvisionVLE Imaging System that utilizes OCT, and SpectraScience, which specializes in light-based diagnostic products for the early detection of disease in various tissues. Other players in the field may include biomedical imaging and diagnostic device manufacturers that incorporate optical biopsy capabilities into their instrumentation. Show Less Read more